Lattice_grid_med
Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Cancer Prevention and Control Overview Sparkline Graph

Graph co-Publications by faculty members in Cancer Prevention and Control

Show all Cancer Prevention and Control members

Publications (total of 1202)

no pagination
Weinberg DS, Lewis N, Sigurdson E, Meyers M. Adenoma/adenocarcinoma (excluding adenomatous polyposis). In: Wexner SD, Stollman N, editors. Diseases of the colon. New York: Informa Healthcare; 2007. p. 477-506.
Wong Y-N, Change W-C, Clapper M, Engstrom PE. Chemoprevention of colorectal cancer. In: Saltz LB, editor. Colorectal cancer : evidence-based chemotherapy strategies. Totowa, N.J.: Humana Press; 2007. p. 33-49.
Wong YN, Chang WC, Clapper M, Engstrom PF. Chemoprevention of colorectal cancer. In: Saltz LB, editor. Colorectal cancer : evidence-based chemotherapy strategies. Totowa, N.J.: Humana Press; 2007. p. 33-50.
Wong YN, Mitra N, Hudes G, Localio R, Schwartz JS, Wan F, Montagnet C, Armstrong K. Survival associated with treatment vs observation of localized prostate cancer in elderly men.[see comment]. Jama. 2006 Dec 13;296(22):2683-93.
Daly MB. Tamoxifen in ductal carcinoma in situ. Semin Oncol. 2006 Dec;33(6):647-9.
Freedman GM, Anderson P, Li TY, Ross E, Swaby R, Goldstein L. Identifying breast cancer patients most likely to benefit from aromatase inhibitor therapy after adjuvant radiation and tamoxifen. Cancer. 2006 Dec;107(11):2552-8.
Hershman D, Hall MJ, Wang XY, Jacobson JS, McBride R, Grann VR, Neugut AI. Timing of adjuvant chemotherapy initiation after surgery for stage III colon cancer. Cancer. 2006 Dec;107(11):2581-8.
Cai KQ, Klein-Szanto A, Karthik D, Edelson M, Daly MB, Ozols RF, Lynch HT, Godwin AK, Xu XX. Age-dependent morphological alterations of human ovaries from populations with and without BRCA mutations. Gynecologic Oncology. 2006 Nov;103(2):719-28.
Fang CY, Daly MB, Miller SM, Zerr T, Malick J, Engstrom P. Coping with ovarian cancer risk: The moderating effects of perceived control on coping and adjustment. Br J Health Psychol. 2006 Nov;11(Pt 4):561-80.
Halbert RJ, Figlin RA, Atkins MB, Bernal M, Hutson TE, Uzzo RG, Bukowski RM, Khan KD, Wood CG, Dubois RW, Peacock S, Apicella C, Andrews L, Tucker K, Bankier A, Daly MB, Hopper JL. Treatment of patients with metastatic renal cell cancer - A RAND appropriateness panel. A discrete choice experiment of preferences for genetic counselling among Jewish women seeking cancer genetics services. Cancer. 2006 Nov;95(10):1448-53.
Fang CY, Ma GX, Miller SM, Tan Y, Su XF, Shive S. A brief smoking cessation intervention for Chinese and Korean American smokers. Preventive Medicine. 2006 Oct;43(4):321-4.
Haile RW, Thomas DC, McGuire V, Felberg A, John EM, Milne RL, Hopper JL, Jenkins MA, Levine AJ, Daly MM, Buys SS, Senie RT, Andrulis IL, Knight JA, Godwin AK, Southey M, McCredie MR, Giles GG, Andrews L, Tucker K, Miron A, Apicella C, Tesoriero A, Bane A, Pike MC, Whittemore AS. BRCA1 and BRCA2 mutation carriers, oral contraceptive use, and breast cancer before age 50. Cancer Epidemiol Biomarkers Prev. 2006 Oct;15(10):1863-70.
Ma GX, Fang CY, Knauer CA, Tan Y, Shive SE. Tobacco dependence, risk perceptions and self-efficacy among Korean American smokers. Addictive behaviors. 2006 Oct;31(10):1776-84.
Movsas B, Diratzouian H, Hanlon A, Cooper H, Freedman G, Konski A, Sigurdson E, Hoffman J, Meropol NJ, Weiner LM, Coia L, Lanciano R, Stein J, Kister D, Eisenberg B. Phase II trial of preoperative chemoradiation with a hyperfractionated radiation boost in locally advanced rectal cancer. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS. 2006 Oct;29(5):435-41.
Valicenti RK, DeSilvio M, Hanks GE, Porter A, Brereton H, Rosenthal SA, Shipley WU, Sandler HM, Haile RW, Thomas DC, McGuire V, Felberg A, John EM, Milne RL, Hopper JL, Jenkins MA, Levine AJ, Daly MM, Buys SS, Senie RT, Andrulis IL, Knight JA, Godwin AK, Southey M, McCredie MR, Giles GG, Andrews L, Tucker K, Miron A, Apicella C, Tesoriero A, Bane A, Pike MC, Whittemore AS. Posttreatment prostatic-specific antigen doubling time as a surrogate endpoint for prostate cancer-specific survival: An analysis of radiation therapy oncology group protocol 92-02 BRCA1 and BRCA2 mutation carriers, oral contraceptive use, and breast cancer before age 50. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS LA English DT Article DE prostate cancer; prostate-specific antigen doubling time; mortality; surrogate endpoint. 2006 Oct;15(10):1863-70.
Jibaja-Weiss ML, Volk RJ, Friedman LC, Granchi TS, Neff NE, Spann SJ, Robinson EK, Aoki N, Beck JR. Preliminary testing of a just-in-time, user-defined values clarification exercise to aid lower literate women in making informed breast cancer treatment decisions. HEALTH EXPECTATIONS. 2006 Sep;9(3):218-31.
Konski A, Watkins-Bruner D, Feigenberg S, Hanlon A, Kulkarni S, Beck JR, Horwitz EM, Pollack A. Using decision analysis to determine the cost-effectiveness of intensity-modulated radiation therapy in the treatment of intermediate risk prostate cancer. Int J Radiat Oncol Biol Phys. 2006 Aug;66(2):408-15.
Locker GY, Kaul K, Weinberg DS, Gatalica Z, Gong G, Peterman A, Lynch J, Klatzco L, Olopade OI, Bomzer CA, Newlin A, Keenan E, Tajuddin M, Knezetic J, Coronel S, Lynch HT. The I1307K APC polymorphism in Ashkenazi Jews with colorectal cancer: clinical and pathologic features. CANCER GENETICS AND CYTOGENETICS. 2006 Aug;169(1):33-8.
McGuire V, John EM, Felberg A, Haile RW, Boyd NF, Thomas DC, Jenkins MA, Milne RL, Daly MB, Ward J, Terry MB, Andrulis IL, Knight JA, Godwin AK, Giles GG, Southey M, West DW, Hopper JL, Whittemore AS. No increased risk of breast cancer associated with alcohol consumption among carriers of BRCA1 and BRCA2 mutations ages < 50 years. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION. 2006 Aug;15(8):1565-7.
Schulz S, Hyslop T, Haaf J, Bonaccorso C, Nielsen K, Witek ME, Birbe R, Palazzo J, Weinberg D, Waldman SA. A Validated Quantitative Assay to Detect Occult Micrometastases by Reverse Transcriptase-Polymerase Chain Reaction of Guanylyl Cyclase C in Patients with Colorectal Cancer. Clin Cancer Res. 2006 Aug;12(15):4545-52.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications by faculty members in Cancer Prevention and Control


Show All Units
Last updated on Tuesday, June 05, 2018